Drugs / JCM-16021
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03457324 | Nov 2018 → Jun 2021 | irritable bowel syndrome | ZhaoXiang Bian | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JCM-16021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03457324 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The Chinese medicine JCM-16021 has been shown to be potentially effective in improving the symptoms of IBS-D based on a small scale clinical trial.” PMID 34774080 ↗ Nov 2021 |